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Myofascial pain definitions, historical 
perspective and further developments
Definitions
The most commonly used definition for myofascial trigger points 
(MTrPs) is that by Travell & Simons (Travell & Simons 1983; 
Simons et al 1999), who define them as hyperirritable areas 
within taut bands of skeletal muscle or fascia. MTrPs are further 
classified as active or latent in nature. An active MTrP produces 
symptoms that can trigger local or referred pain, whereas a latent 
MTrP does not trigger pain unless being stimulated (Dommerholt 
et al 2011). Active MTrPs found in a specific region of the body 
such as the neck, back and shoulder, are often referred to as a 
myofascial pain syndrome, or MPS (Simons et al 1999). 
MTrPs feature the hallmark characteristics of MPS and may 
exhibit motor, sensory and autonomic components (Dommerholt 
et al 2011).The motor component of active and latent MTrPs 
may include restricted range of motion (ROM) (Grieve et al 
2011; Grieve et al 2013). Latent MTrPs may also alter the timing 
and decrease the consistency of the muscle activation pattern 
(MAP) of scapular rotator muscles (Lucas et al 2004, 2010), and 
may inhibit normal motor activity in the muscle of origin or in 
functionally related muscles. Motor inhibition is often identified 
clinically as muscle weakness, poor co-ordination and muscle 
imbalance (McPartland & Simons 2011); although MTrP motor 
effects have gone largely unrecognised because of a lack of 
published research studies (McPartland & Simons 2011).
MTrPs may also be associated with autonomic signs including 
changes in skin temperature, skin colour, piloerection 
(goosebumps) and lacrimation (shedding of tears) (Gerwin 
2010). Sensory components may include local tenderness, 
referred pain, and peripheral and central sensitisation 
(Dommerholt et al 2011). Peripheral sensitisation is a reduction 
in threshold and an increase in responsiveness of the peripheral 
nocioceptors, central sensitisation is an increased responsiveness 
of neurons in the central nervous system (CNS) (Dommerholt et 
al 2011). The signs of peripheral and central sensitisation are 
hyperalgesia (an increased response to a stimulus that is normally 
painful), allodynia (pain due to stimulus that does not normally 
provoke pain) and referred pain, which may become chronic and 
widespread (Meeus & Nijs 2007; Dommerholt et al 2011). 
Further research is needed to investigate the relationship between 
central sensitisation and MTrP formation as there is no evidence to 
support that central sensitisation induces the development of new 
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MTrPs (Ge et al 2011). Recent exploration by Fernández-de-las-
Peñas and Dommerholt (2014) into whether TrPs are a peripheral 
or central phenomenon highlighted, in summary, the growing 
literature supporting the concept of TrPs starting as a peripheral 
process that can contribute to and maintain central sensitisation.
In relation to MTrP definitions and terminology is the growing 
awareness of fascia and its role in musculoskeletal dysfunction. 
Fascia is a connective tissue which surrounds every nerve, 
blood vessel and muscle fibre in the human body resulting in 
the connection of bones, muscles and organs which form large 
networks throughout the body (Schleip et al 2012a). Based on 
the tensegrity principle, previous studies have highlighted the 
presence of continuity 
and connectivity between 
fascia or muscle that may 
be anatomically distant 
from each other (Langevin 
2006; Kassolik et al 2009). 
Anatomical dissections 
have confirmed the 
continuity of the fascial 
system in the upper and 
lower limbs (Stecco et al 
2007, 2008). Anatomy 
trains, a schematic 
map of the body’s 
fascia connections, has 
suggested and proposed that any tension at a particular part 
of an “anatomy train” may have detrimental effects resulting in 
global decreased flexibility (Myers 2014). Myofascial therapies 
cover a numerous and varied spectrum of techniques, including 
osteopathic soft-tissue techniques, structural integration (Rolfing), 
massage including connective tissue massage (CTM), instrument 
assisted fascial release, MTrP therapy, strain / counter-strain and 
muscle energy technique (MET) (Simmonds et al 2012).
In clinical practice, it is sometimes difficult to ascertain if a 
fascial or MTrP intervention will target only the fascia, or reach 
both the underlying muscle and associated MTrPs. Specific 
treatments aimed at the fascia may need to review the possible 
impact on MTrPs and be aware of the integral link between 
muscle and enveloping fascia (epimysium), muscle fibre bundles 
(perimysium), and individual muscle fibres (endomysium) 
(Dommerholt 2012).
The early historical perspective
The evolution of the term MTrP can be linked to the unknown 
cause of muscle pain developing in an otherwise fit person which, 
for centuries, remained an enigma and consequently meant that 
no general agreement on what to call the underlying disorder 
could be reached (Cummings & Baldry 2007). Through the years, 
individual authors have taken a cluster of signs and symptoms 
and allocated them a variety of names or, even more confusingly, 
assigned different signs and symptoms to something with an 
already established name (Simons 1990), for example:
 l muscle callus (Froriep 1843)
 l muscular rheumatism (Adler 1900)
 l fibrositis (Gowers 1904; Kelly 1941)
 l myalgic spots / nodules (Good 1942)
 l spot tenderness (first description of MTrPs by Travell et al 
1942).
Some of these listed historical terms and authors have been 
identified and cited by Simons et al (1999) as evidence for the 
evolution of MTrP theory.
Following an experimental study on referred pain from muscle 
(Kellgren 1938), three clinicians, researching independently on 
three different continents (Kelly 1941; Good 1942; Travell et al 
1942), published a series of studies emphasising four cardinal 
features of a MTrP:
 l a palpable nodule or band like hardness in the muscle 
 l a highly localised spot of extreme tenderness in that band
 l reproduction of the patient’s distant pain complaint by digital 
pressure on that spot 
 l relief of the pain by massage or injection of the tender spot.
According to Mense and Simons (2001), these three publications 
(Kelly 1941; Good 1942; Travell et al 1942) were pivotal in the 
development and background to our understanding of MPS 
caused by MTrPs. In reviewing each of these three proposed 
pivotal studies in the evolution of the MTrP concept (Kelly 1941; 
Good 1942; Travell et al 1942), it is clear that the authors paid 
tribute to the influential work of Kellgren (1938). All three had 
identified MTrPs. However, each used different diagnostic terms to 
identify and describe them. 
A preliminary observational study on referred pain arising from 
muscles of normal subjects was performed by Kellgren (1938). 
These experiments were conducted in the laboratory of Sir Thomas 
Lewis (University College London) and involved Kellgren injecting 
a hypertonic saline solution into specific muscles on himself and 
other workers in his laboratory. Kellgren (1938) based his study 
on previous work by Lewis (1938), who had found that injecting 
substances (not specified) into muscle had the identical effect 
to that resulting from ischaemic conditions and, therefore, was 
claimed to represent true muscle pain.
To ensure muscular pain was being assessed, Kellgren (1938) 
used Novocaine to anaesthetise the overlying skin before  
injecting a saline solution into the muscle. The investigation 
included muscles of the trunk, hand, lower and upper limb, and 
concluded that fascia and tendon sheaths give sharply localised 
pain, while muscle gives diffuse pain which may be referred 
(Kellgren 1938). Any underlying causes of the referred pain,  
such as overuse, trauma, or surgery were not made clear, but 
further findings were that diffuse pain from a given muscle is 
always distributed within certain regions, although the distribution 
within these limits varies between individuals (Kellgren 1938).  
The distribution of the diffuse muscle pain appears to follow a 
spinal segmental pattern and that pain from muscle may be 
confused with pain arising from deep structures such as the joints 
(Kellgren 1938). 
The tensegrity principle is a 
proposed concept of muscular 
skeletal relationships which refers 
to the forces of tension provided by 
muscles, tendons, ligaments and 
fascia on bones and joints. It is not 
within the scope of this article to 
fully develop the complex concept 
of tensegrity. Fuller explanations 
are provided by the following 
influential fascial texts: Anatomy 
Trains (Myers 2014) and Fascia: 
The Tensional Network of the 
Human Body (Schleip et al 2012b).
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Kellgren (1938) concluded that the mechanism of pain referral 
from muscle and joints follows a final common path in the CNS. 
This early view of the possible mechanism of muscle pain and 
nature of MTrPs was echoed years later by Lucas et al (2004) 
who stated that MTrPs are not just contracted muscle fibres, but 
neuromuscular lesions that form part of the neurological loop that 
affects, and is affected, by the CNS. 
All experiments by Kellgren (1938) were performed on 
asymptomatic individuals and pain was induced by the introduction 
of saline solution. This influential study in the field of myofascial 
and MTrP pain illustrates the possible confusion between the 
origin of pain (differential diagnosis joint and muscle) and the fact 
that pain can be referred from muscle. Whether injecting localised 
saline can be compared to MTrP, e.g. nodule, taut band, localised 
tender area, in its signs and symptoms is an important question. 
The research by Kellgren (1938) provides a foundation for the 
understanding of the existence of MTrPs.
Kelly (1941) investigated and treated 200 cases of somatic pain 
(fibrositis) that were with, or without, co-existing pain in the region 
of joints. The main assertion in the case series was the presence 
of a muscular lesion (nodule) in all cases of pain of uncertain 
origin. Nodules were found in the:
 l gluteus maximus, erector spinae (lower back pain)
 l gluteus maximus near ischael tuberosity (sciatica)
 l intercostals, erector spinae (chest pain)
 l upper trapezius, occipital region (neck pain)
 l anterior deltoid (upper extremity pain)
 l wrist extensors (tennis elbow)
 l medial longitudinal arch muscles (foot strain)
 l soleus, gastrocnemius (knee joint pain). 
Some of these observations on muscular nodules correlate with 
more recent findings by Travell & Simons (1983; 1992) and 
Simons et al (1999) in which mapping of MTrPs and regional pain 
was undertaken. 
Good (1942) identified myalgic spots and pain referral patterns 
for 20 muscles in the upper and lower quadrant, in 500 cases 
of myalgia in the British army. The objective signs for myalgia 
revolved around myalgic spots, which were well-defined tender 
areas in the origin, insertion and course of muscle. Good (1942) 
linked these myalgic spots with well-defined nodules that may, 
or may not, be present in the muscle. Pressure on these myalgic 
spots elicited a severe pain often similar to the spontaneous 
pain complaint and a pathogenic sign of wincing, or involuntary 
movement similar to the “jump sign”, which was identified as a 
diagnostic criterion of MTrPs in later work by Travell & Simons 
(1983) and Simons et al (1999). In findings similar to those 
of Kellgren (1938), Good (1942) concluded that referred pain 
was often dermatomal in distribution, and from myalgic spots in 
muscles supplied by the same spinal segments. 
In a further case series, Travell et al (1942) recruited 58 people 
with shoulder and / or arm pain. In the majority of cases the onset 
was gradual, with precipitating factors ranging from physical 
fatigue, chilling, infection, trauma, muscular inactivity and poor 
posture (protracted shoulder girdle). In stark contrast to Kelly 
(1941) and Good (1942) who referred exclusively to nodules 
and myalgic spots, Travell et al (1942) used the term trigger 
point (TrP) and described how all the cases presented with one 
or more TrP. The main criteria for identification of a TrP included 
excruciating tenderness on strong pressure, pressure eliciting pain 
in the reference zone, active contraction or passive stretching of 
the muscle inducing referred pain. Apart from serratus posterior 
and infraspinatus, for which referral patterns were clearly linked 
to their dermatome distribution, Travell et al (1942) asserted that 
reference patterns did not clearly align with somatic reference 
zones mapped out for single spinal segments (Kellgren 1938), 
and concluded that idiopathic myalgia best described the 
syndrome of a restriction of motion primarily as a reaction to pain. 
This is the first mention of the word syndrome that may provide 
evidence for the existence of MTrPs and related muscle pain and, 
as previously asserted, one of the key definitions in MTrP literature 
is the related term MPS.
Dr Janet Travell, the author of this pivotal study in the history and 
understanding of MTrPs, was a cardiologist treating patients with 
life-threatening pulmonary disease (Mense & Simons 2001). 
Some of her patients complained more about the devastating 
pain in their shoulders and arms than about their major illness 
and, on examination through systematic palpation of the scapula 
and chest muscles, Travell uncovered the presence of trigger 
areas. In her autobiography, Of!ce Hours: Day and Night (1968), 
Travell noted that palpation of her own shoulder pain and 
presence of “sore spots” was her first introduction to “enigmatic 
trigger areas”. It was at this time that she read a study by Edeiken 
and Wolferth (1936) on persistent pain in the shoulder following 
myocardial infarction and, like previous clinicians (Kelly 1941; 
Good 1942) she was influenced by the findings of Kellgren (1938). 
Further to the three previously mentioned influential case series, 
Travell and Rinzler (1952) published a study on “The Myofascial 
Genesis of Pain”, which reported pain patterns of MTrPs in 32 
skeletal muscles from a sample population of 1,000 patients with 
MPS. As in Travell et al (1942), there was minimal explanation of 
the histology and pathophysiology, and nothing relating to the 
exact mechanism of pain referral. The 32 muscles and TrP referral 
patterns were later included in the two volume book entitled 
Myofascial Pain and Dysfunction, The Trigger Point Manual (Travell 
& Simons 1983; Travell & Simons 1992) and again in the later 
second edition (Simons et al 1999).
The historical literature is largely based on a multiple case 
study, or case series approach, the design and method of which 
may help in the discovery of new diseases, provide new ideas 
in medicine (Vandenbroucke 2001), have the advantages of 
replication across a number of cases, and have the ability to 
strengthen theory (DePoy & Gitlin 2005). However, there are 
limitations of a case series in respect of the descriptive nature, 
lack of a control / comparison group and susceptibility to bias 
(Kooistra et al 2009). 
Although the publications mentioned stem from the 1930s and 
40s, it could be argued that the basis of MTrP theory has not 
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changed considerably to the present day. The early pioneering 
work, specifically by Travell and later in collaboration with David 
Simons, has remained the foundation of MTrP theory.
Further developments
While the focus of this article is primarily on an aspect of the 
historical basis of MPS and MTrP theory, the reader is advised to 
explore some of the later developments, related key evidence to 
support your use and / or critical appraisal of MTrP therapy, and 
possible gaps in the literature in relation to the following:
 l pathophysiology of MTrPs integrated hypothesis (Simons et al 
1999) 
 l presence of noxious chemicals in MTrPs as a possible 
explanation for the persistence of pain associated with MTrPs 
(Shah et al 2005, 2008)
 l absence of laboratory methods or imaging to objectively 
confirm or diagnose a MTrP, developments in Magnetic 
Resonance Elastography (MRE) (Chen et al 2007); Doppler 
Ultrasound (Sikdaret al 2009 ) and advancements in 
ultrasound elastography (measures tissue stiffness) in relation 
to MTrP diagnosis (Brandenburg et al 2014)
 l reliability issues in relation to physical examination and 
palpation for the diagnosis of MTrPs (Lucas et al 2009; 
Myburgh et al 2008) 
 l increased discussion in relation to peripheral and central 
sensitisation as an explanation for the chronicity and referred 
pain in MPS (Ge et al 2011; Fernández-de-las-Peñas & 
Dommerholt 2014).
The later developments and related key evidence described 
previously are an example of the increased research evidence 
in today’s MPS / MTrP literature. The current research evidence 
uses many types of design, from case studies to multi-centre 
randomised controlled trials (RCT). Some of the available 
evidence is of high quality and some has limitations in respect 
of scientific rigour and associated internal and external validity 
issues.
Importantly, the focus of this article is not on the clinical efficacy, 
or related research evidence in respect of myofascial pain and 
MTrP therapy for specific conditions or regional pain. Instead, the 
aim is to provide you with some of the important evidence based 
definitions, historical background, later developments and related 
key research evidence that may critically inform your clinical 
practice in relation to myofascial pain and MTrP therapy. A recent 
evidence-informed review of the current myofascial pain literature 
included publications originating from many countries, including 
Australia, Brazil, Columbia, Denmark, Italy, Iran, Israel, Japan, New 
Zealand, Qatar, South Korea, Spain, Turkey, the UK and the United 
States, which reflects the widespread interest in myofascial pain 
and related research evidence (Dommerholt et al 2015).
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